Federal contract award

75FCMC24F0202

END STAGE RENAL DISEASE (ESRD) TREATMENT CHOICES (ETC) MODEL PROGRAM ANALYSIS AND TECHNICAL SUPPORT

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeOFC OF ACQUISITION AND GRANTS MGMT
NAICS541720 — Research and Development in the Social Sciences and Humanities
PSCAN42 — HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH
Parent award / vehicle75FCMC19D0082
Set-asideNot reported
Pricing typeCOST PLUS FIXED FEE
Obligations$4.2M
Current contract value$4.2M
Potential contract value / ceiling$4.2M
Start dateSep 20, 2024
Current end dateSep 19, 2027
Potential end dateSep 19, 2027
Latest award activityJul 9, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 10 of 10 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jul 9, 2026P00009$0PROVIDE OPERATIONAL AND PROGRAMMATIC SUPPORT FOR DMPM'S MULTI-PAYER MODELS, INCLUDING ANALYSIS, DESIGN, MEASUREMENT, AND ASSESSMENT SUPPORT.
Jul 7, 2026P00008$0PROVIDE OPERATIONAL AND PROGRAMMATIC SUPPORT FOR DMPM'S MULTI-PAYER MODELS, INCLUDING ANALYSIS, DESIGN, MEASUREMENT, AND ASSESSMENT SUPPORT.
Jun 24, 2026P00007$0PROVIDE OPERATIONAL AND PROGRAMMATIC SUPPORT FOR DMPM'S MULTI-PAYER MODELS, INCLUDING ANALYSIS, DESIGN, MEASUREMENT, AND ASSESSMENT SUPPORT.
Apr 30, 2026P00006$0PROVIDE OPERATIONAL AND PROGRAMMATIC SUPPORT FOR DMPM'S MULTI-PAYER MODELS, INCLUDING ANALYSIS, DESIGN, MEASUREMENT, AND ASSESSMENT SUPPORT.
Mar 26, 2026P00005$0EOI:: IMPLEMENTING EO 14222 HHS COST EFFICIENCY INITIATIVE(MARCH 19, 2025)::EOI MODIFICATION TO DESCOPE PROVIDE OPERATIONAL AND PROGRAMMATIC SUPPORT FOR DMPM'S MULTI-PAYER MODELS, INCLUDING ANALYSIS, DESIGN, MEASUREMENT, AND ASSESSMENT SUPPORT.
Sep 5, 2025P00004$1.4MPROVIDE OPERATIONAL AND PROGRAMMATIC SUPPORT FOR DMPM'S MULTI-PAYER MODELS, INCLUDING ANALYSIS, DESIGN, MEASUREMENT, AND ASSESSMENT SUPPORT.
Aug 1, 2025P00003$0EOI:: IMPLEMENTING EO 14222 HHS COST EFFICIENCY INITIATIVE(MARCH 19, 2025)::EOI MODIFICATION TO DESCOPE PROVIDE OPERATIONAL AND PROGRAMMATIC SUPPORT FOR DMPM'S MULTI-PAYER MODELS, INCLUDING ANALYSIS, DESIGN, MEASUREMENT, AND ASSESSMENT SUPPORT.
Mar 12, 2025P00002$0END STAGE RENAL DISEASE (ESRD) TREATMENT CHOICES (ETC) MODEL PROGRAM ANALYSIS AND TECHNICAL SUPPORT
Mar 3, 2025P00001$0END STAGE RENAL DISEASE (ESRD) TREATMENT CHOICES (ETC) MODEL PROGRAM ANALYSIS AND TECHNICAL SUPPORT
Sep 11, 20240$2.8MEND STAGE RENAL DISEASE (ESRD) TREATMENT CHOICES (ETC) MODEL PROGRAM ANALYSIS AND TECHNICAL SUPPORT

Estimated positioning window

Oct 25, 2026 – Mar 19, 2027

Recompete signal:
85/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 85/100. Available recorded signals: 80 points.

Contract end 2027-09-19 (329 days from calculation)
+35 points
103 historical awards in this buyer and category group
+15 points
10 recorded award transactions
+10 points
Latest award action: 2026-07-09
+5 points
Parent award identifier recorded
+5 points
Solicitation identifier recorded
+10 points
Linked official forecast
+0 points
Calculated on
2026-10-25 10:18:04.631876+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Oct 25, 2026.

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.